Step Pharma Alternatives & Competitors
12 companies similar to Step Pharma — Developing selective inhibitors of CTPS1 for patients with cancer and auto-immun...
Companies similar to Step Pharma
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditio...
Odyssey Therapeutics
Building a machine learning-based platform to develop novel therapeutics focusing on cance...
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Boston, United States
Kanaph Therapeutics
We are the leader of next generation immuno-oncology and autoimmune diseases.
Seoul, Korea South
Rival Readout
Competing with Step Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
OncXerna Therapeutics
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...
Waltham, United States
Pacylex Pharmaceuticals, Inc.
A new target in cancer care - triggering selective lethality with a new class of drugs.
Edmonton, Canada
Lisata Therapeutics, Inc.
Targeted Therapy Delivered
United States
Bolt Biotherapeutics, Inc.
Plans to develop a novel format for T-cell mediated anti-tumour therapy
Redwood City, United Stat...
BiPar Sciences
Innovative therapies harnessing the power of PARP inhibitors to combat advanced cancers
Captor Therapeutics SA
Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the diffic...
Poland
Sitryx
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...
Oxford, United Kingdom
About Step Pharma
Step Pharma is a France-based biotechnology and pharmaceutical company, founded in 2014, that specializes in developing selective inhibitors of CTPS1 (cytidine triphosphate synthase 1) for the treatment of cancer and autoimmune diseases. The company's lead program, dencatistat (STP938), is a potent, selective, oral inh...
Development of targeted oncology therapies
Patients with various cancer types
CTPS1 Inhibitors, Oncology, Autoimmune Diseases, Biopharmaceuticals, Clinical Development, Cancer Therapy, Biomarker Selection, Genetic Immunodeficiencies Research, Synthetic Lethality, Biotech Research, Biomarker-driven Therapy, Drug Discovery, Tumor Agnostic Approach, Immunotherapy, Venture-backed Biotech
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Step Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Step Pharma on 7 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
